Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	51.93	43.66	28.74
Graham Fair Price	2.25	8.67	8.48
PEG	inf	0.00	1.45
Price/Book	14.77	1.51	1.32
Price/Cash Flow	16.44	-148.55	127.58
Prices/Earnings	18.25	10.69	9.04
Price/Sales	20.95	4.04	3.34
Price/FCF	16.44	-148.55	127.58
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.09	0.18	0.16
Operating Margin	9.68	0.12	0.11
ROA	-0.10	0.02	0.02
ROE	0.04	0.04	-2.94
ROIC	0.02	0.02	5.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.06	-85.70
Dividends QOQ	-0.80	0.05	-93.77
EBIT QOQ	0.25	0.08	-68.36
EPS QOQ	0.06	0.00	inf
FCF QOQ	-0.57	-2.02	-252.26
Revenue QOQ	0.04	-0.02	-65.14
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.62	46.78	-1.76
Days Sales Outstanding (DSO)	45.66	47.78	4.64
Inventory Turnover	1.89	1.92	1.79
Debt/Capitalization	0.40	0.39	-2.31
Quick Ratio	0.46	0.51	11.90
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.36	9.72	3.79
Cash	0.90	0.87	-3.08
Capex	-0.25	-0.31	-24.00
Free Cash Flow	0.10	-0.10	2.31
Revenue	3.70	3.64	-1.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.76	0.88	15.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.92	11.94	33.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating